Thomas J. Herzfeld Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,850
| Closed | -$349K | – | 233 |
|
|
2023
Q3 | $349K | Hold |
2,850
| – | – | 0.13% | 79 |
|
|
2023
Q2 | $362K | Hold |
2,850
| – | – | 0.14% | 71 |
|
|
2023
Q1 | $368K | Hold |
2,850
| – | – | 0.15% | 65 |
|
|
2022
Q4 | $374K | Hold |
2,850
| – | – | 0.15% | 71 |
|
|
2022
Q3 | $333K | Hold |
2,850
| – | – | 0.14% | 68 |
|
|
2022
Q2 | $335K | Hold |
2,850
| – | – | 0.14% | 76 |
|
|
2022
Q1 | $371K | Hold |
2,850
| – | – | 0.14% | 80 |
|
|
2021
Q4 | $435K | Hold |
2,850
| – | – | 0.16% | 85 |
|
|
2021
Q3 | $461K | Hold |
2,850
| – | – | 0.2% | 72 |
|
|
2021
Q2 | $466K | Sell |
2,850
-2,700
| -49% | -$416K | 0.19% | 76 |
|
|
2021
Q1 | $836K | Hold |
5,550
| – | – | 0.38% | 65 |
|
|
2020
Q4 | $841K | Hold |
5,550
| – | – | 0.39% | 62 |
|
|
2020
Q3 | $725K | Hold |
5,550
| – | – | 0.49% | 41 |
|
|
2020
Q2 | $746K | Hold |
5,550
| – | – | 0.37% | 56 |
|
|
2020
Q1 | $598K | Hold |
5,550
| – | – | 0.32% | 61 |
|
|
2019
Q4 | $669K | Hold |
5,550
| – | – | 0.24% | 71 |
|
|
2019
Q3 | $552K | Hold |
5,550
| – | – | 0.2% | 84 |
|
|
2019
Q2 | $606K | Buy |
+5,550
| New | +$590K | 0.23% | 85 |
|
|
2019
Q1 | – | Sell |
-5,100
| Closed | -$492K | – | 300 |
|
|
2018
Q4 | $492K | Hold |
5,100
| – | – | 0.2% | 97 |
|
|
2018
Q3 | $622K | Hold |
5,100
| – | – | 0.22% | 81 |
|
|
2018
Q2 | $560K | Hold |
5,100
| – | – | 0.2% | 85 |
|
|
2018
Q1 | $544K | Hold |
5,100
| – | – | 0.21% | 82 |
|
|
2017
Q4 | $545K | Buy |
5,100
+3,300
| +183% | +$353K | 0.2% | 73 |
|
|
2017
Q3 | $200K | Hold |
1,800
| – | – | 0.09% | 98 |
|
|
2017
Q2 | $186K | Hold |
1,800
| – | – | 0.08% | 107 |
|
|
2017
Q1 | $176K | Hold |
1,800
| – | – | 0.08% | 122 |
|
|
2016
Q4 | $159K | Buy |
1,800
+492
| +38% | +$44.8K | 0.07% | 119 |
|
|
2016
Q3 | $126K | Hold |
1,308
| – | – | 0.07% | 119 |
|
|
2016
Q2 | $112K | Hold |
1,308
| – | – | 0.06% | 142 |
|
|
2016
Q1 | $114K | Buy |
1,308
+1,200
| +1,111% | +$107K | 0.06% | 149 |
|
|
2015
Q4 | $12K | Hold |
108
| – | – | ﹤0.01% | 296 |
|
|
2015
Q3 | $11K | Hold |
108
| – | – | ﹤0.01% | 300 |
|
|
2015
Q2 | $13K | Hold |
108
| – | – | 0.01% | 281 |
|
|
2015
Q1 | $12K | Hold |
108
| – | – | 0.01% | 271 |
|
|
2014
Q4 | $11K | Hold |
108
| – | – | 0.01% | 224 |
|
|
2014
Q3 | $10K | Hold |
108
| – | – | 0.01% | 240 |
|
|
2014
Q2 | $9K | Buy |
+108
| New | +$8.51K | 0.01% | 248 |
|
Other funds holding IBB
CB
Thomas J. Herzfeld Advisors's IBB Position: Q4 2023 in Review
Thomas J. Herzfeld Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 2,850 shares — an estimated $349K sold.
Thomas J. Herzfeld Advisors first reported a position in IBB in Q2 2014 and held it in 37 quarters. The position peaked at $841K in Q4 2020. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2023.
- Thomas J. Herzfeld Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
- Thomas J. Herzfeld Advisors sold 2,850 iShares Biotechnology ETF shares in Q4 2023, an estimated $349K.
- Thomas J. Herzfeld Advisors first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 37 quarters.
- Thomas J. Herzfeld Advisors's iShares Biotechnology ETF position peaked at $841K in Q4 2020.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.
Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.